Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

NCT07606066 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07606066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07606066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
May 6, 2026
Completion date
March 31, 2027
Enrollment
2,150 (estimated)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes